Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

United Therapeutic (NQ: UTHR )

217.22 +3.74 (+1.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 392,076
Open 214.52
Bid (Size) 213.51 (1)
Ask (Size) 220.59 (1)
Prev. Close 213.48
Today's Range 212.99 - 217.68
52wk Range 201.65 - 283.09
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside. 
Via MarketBeat
Exposures Product Safety
United Therapeutics's Return On Capital Employed Insights
 
Via Benzinga

Performance

YTD
-20.53%
-20.53%
1 Month
-0.54%
-0.54%
3 Month
-12.65%
-12.65%
6 Month
-22.02%
-22.02%
1 Year
-4.82%
-4.82%

More News

Read More
The Latest Analyst Ratings for United Therapeutics
Via Benzinga
Why United Therapeutics Shares Are Falling Today
Via Benzinga
Recap: United Therapeutics Q1 Earnings
Via Benzinga
United Therapeutics Corporation Reports First Quarter 2023 Financial Results
From United Therapeutics Corporation
Via Business Wire
Analyst Expectations for United Therapeutics's Future
Via Benzinga
This Foreboding Sign Looms Over United Therapeutics's Chart
Via Benzinga
Earnings Outlook For United Therapeutics
Via Benzinga
Analyst Ratings for United Therapeutics
Via Benzinga
United Therapeutics Corporation to Report First Quarter 2023 Financial Results Before the Market Opens on Wednesday, May 3, 2023
From United Therapeutics Corporation
Via Business Wire
7 Biotech Stocks That Could Cure Your Portfolio Woes
Via InvestorPlace
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at Upcoming Scientific Meetings
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation to Present at the Cowen 43rd Annual Health Care Conference
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2022 Financial Results Before the Market Opens on Wednesday, February 22, 2023
From United Therapeutics Corporation
Via Business Wire
Want To Copy 'Master Trader' Nancy Pelosi's Investments? There's An ETF For That. Here Are The Holdings
Via Benzinga
Earnings Scheduled For February 22, 2023
Via Benzinga
3 Biotech Companies to Watch in 2023
Via InvestorPlace
Crocs, Lamb Weston And These 3 Stocks Insiders Are Selling
Via Benzinga
Alphabet And These 2 Healthcare Stocks Insiders Are Selling
Via Benzinga
United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
Should SMLF Be On Your Investing Radar?
Via Talk Markets
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 10
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.